nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Haematuria—Epirubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Budesonide—Dizziness—Ifosfamide—testicular cancer	0.000994	0.000994	CcSEcCtD
Budesonide—Pharyngitis—Methotrexate—testicular cancer	0.000994	0.000994	CcSEcCtD
Budesonide—Urinary tract disorder—Methotrexate—testicular cancer	0.000989	0.000989	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Budesonide—Epistaxis—Epirubicin—testicular cancer	0.000985	0.000985	CcSEcCtD
Budesonide—Urethral disorder—Methotrexate—testicular cancer	0.000982	0.000982	CcSEcCtD
Budesonide—Sinusitis—Epirubicin—testicular cancer	0.000979	0.000979	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—testicular cancer	0.000979	0.000979	CcSEcCtD
Budesonide—Nausea—Dactinomycin—testicular cancer	0.000975	0.000975	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—testicular cancer	0.000971	0.000971	CcSEcCtD
Budesonide—Infestation—Doxorubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Budesonide—Visual impairment—Methotrexate—testicular cancer	0.000965	0.000965	CcSEcCtD
Budesonide—Vomiting—Ifosfamide—testicular cancer	0.000956	0.000956	CcSEcCtD
Budesonide—Hypersensitivity—Cisplatin—testicular cancer	0.000955	0.000955	CcSEcCtD
Budesonide—Rash—Ifosfamide—testicular cancer	0.000948	0.000948	CcSEcCtD
Budesonide—Dermatitis—Ifosfamide—testicular cancer	0.000947	0.000947	CcSEcCtD
Budesonide—Urticaria—Etoposide—testicular cancer	0.000944	0.000944	CcSEcCtD
Budesonide—Haemoglobin—Epirubicin—testicular cancer	0.000942	0.000942	CcSEcCtD
Budesonide—Rhinitis—Epirubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—testicular cancer	0.000939	0.000939	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—testicular cancer	0.000939	0.000939	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Budesonide—Haemorrhage—Epirubicin—testicular cancer	0.000937	0.000937	CcSEcCtD
Budesonide—Eye disorder—Methotrexate—testicular cancer	0.000936	0.000936	CcSEcCtD
Budesonide—Asthenia—Cisplatin—testicular cancer	0.00093	0.00093	CcSEcCtD
Budesonide—Pharyngitis—Epirubicin—testicular cancer	0.00093	0.00093	CcSEcCtD
Budesonide—Cardiac disorder—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Budesonide—Urinary tract disorder—Epirubicin—testicular cancer	0.000925	0.000925	CcSEcCtD
Budesonide—Oedema peripheral—Epirubicin—testicular cancer	0.000923	0.000923	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Budesonide—Connective tissue disorder—Epirubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Budesonide—Urethral disorder—Epirubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—testicular cancer	0.000911	0.000911	CcSEcCtD
Budesonide—Angiopathy—Methotrexate—testicular cancer	0.000908	0.000908	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—testicular cancer	0.000906	0.000906	CcSEcCtD
Budesonide—Immune system disorder—Methotrexate—testicular cancer	0.000904	0.000904	CcSEcCtD
Budesonide—Visual impairment—Epirubicin—testicular cancer	0.000903	0.000903	CcSEcCtD
Budesonide—Mediastinal disorder—Methotrexate—testicular cancer	0.000902	0.000902	CcSEcCtD
Budesonide—Nausea—Ifosfamide—testicular cancer	0.000893	0.000893	CcSEcCtD
Budesonide—Diarrhoea—Cisplatin—testicular cancer	0.000887	0.000887	CcSEcCtD
Budesonide—Alopecia—Methotrexate—testicular cancer	0.000885	0.000885	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—testicular cancer	0.000877	0.000877	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—testicular cancer	0.000875	0.000875	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—testicular cancer	0.000872	0.000872	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—testicular cancer	0.000871	0.000871	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Budesonide—Flushing—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—testicular cancer	0.000867	0.000867	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000856	0.000856	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—testicular cancer	0.000854	0.000854	CcSEcCtD
Budesonide—Asthenia—Etoposide—testicular cancer	0.000852	0.000852	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—testicular cancer	0.00085	0.00085	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—testicular cancer	0.00085	0.00085	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Budesonide—Back pain—Methotrexate—testicular cancer	0.000843	0.000843	CcSEcCtD
Budesonide—Pruritus—Etoposide—testicular cancer	0.00084	0.00084	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Budesonide—Alopecia—Epirubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Budesonide—Vomiting—Cisplatin—testicular cancer	0.000824	0.000824	CcSEcCtD
Budesonide—Vision blurred—Methotrexate—testicular cancer	0.000821	0.000821	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—testicular cancer	0.000821	0.000821	CcSEcCtD
Budesonide—Rash—Cisplatin—testicular cancer	0.000817	0.000817	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—testicular cancer	0.000817	0.000817	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—testicular cancer	0.000813	0.000813	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—testicular cancer	0.000809	0.000809	CcSEcCtD
Budesonide—Anaemia—Methotrexate—testicular cancer	0.000806	0.000806	CcSEcCtD
Budesonide—Flushing—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Budesonide—Flatulence—Epirubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Budesonide—Tension—Epirubicin—testicular cancer	0.0008	0.0008	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Budesonide—Nervousness—Epirubicin—testicular cancer	0.000792	0.000792	CcSEcCtD
Budesonide—Back pain—Epirubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—testicular cancer	0.000787	0.000787	CcSEcCtD
Budesonide—Malaise—Methotrexate—testicular cancer	0.000786	0.000786	CcSEcCtD
Budesonide—Dizziness—Etoposide—testicular cancer	0.000785	0.000785	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Budesonide—Vertigo—Methotrexate—testicular cancer	0.000783	0.000783	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Budesonide—Nausea—Cisplatin—testicular cancer	0.00077	0.00077	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—testicular cancer	0.000769	0.000769	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Budesonide—Cough—Methotrexate—testicular cancer	0.000761	0.000761	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Budesonide—Vomiting—Etoposide—testicular cancer	0.000755	0.000755	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Budesonide—Anaemia—Epirubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Budesonide—Agitation—Epirubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Budesonide—Rash—Etoposide—testicular cancer	0.000749	0.000749	CcSEcCtD
Budesonide—Dermatitis—Etoposide—testicular cancer	0.000748	0.000748	CcSEcCtD
Budesonide—Headache—Etoposide—testicular cancer	0.000744	0.000744	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—testicular cancer	0.000742	0.000742	CcSEcCtD
Budesonide—Myalgia—Methotrexate—testicular cancer	0.000742	0.000742	CcSEcCtD
Budesonide—Chest pain—Methotrexate—testicular cancer	0.000742	0.000742	CcSEcCtD
Budesonide—Tension—Doxorubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000737	0.000737	CcSEcCtD
Budesonide—Malaise—Epirubicin—testicular cancer	0.000736	0.000736	CcSEcCtD
Budesonide—Discomfort—Methotrexate—testicular cancer	0.000733	0.000733	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Budesonide—Vertigo—Epirubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Budesonide—Syncope—Epirubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Budesonide—Back pain—Doxorubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—testicular cancer	0.000726	0.000726	CcSEcCtD
Budesonide—Palpitations—Epirubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Budesonide—Confusional state—Methotrexate—testicular cancer	0.000717	0.000717	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—testicular cancer	0.000717	0.000717	CcSEcCtD
Budesonide—Cough—Epirubicin—testicular cancer	0.000712	0.000712	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—testicular cancer	0.000711	0.000711	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Budesonide—Infection—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Budesonide—Nausea—Etoposide—testicular cancer	0.000705	0.000705	CcSEcCtD
Budesonide—Hypertension—Epirubicin—testicular cancer	0.000704	0.000704	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—testicular cancer	0.000698	0.000698	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Budesonide—Myalgia—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Budesonide—Chest pain—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Budesonide—Agitation—Doxorubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Budesonide—Anxiety—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—testicular cancer	0.000691	0.000691	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00069	0.00069	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—testicular cancer	0.000688	0.000688	CcSEcCtD
Budesonide—Discomfort—Epirubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Budesonide—Malaise—Doxorubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—testicular cancer	0.000678	0.000678	CcSEcCtD
Budesonide—Anorexia—Methotrexate—testicular cancer	0.000678	0.000678	CcSEcCtD
Budesonide—Syncope—Doxorubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Budesonide—Confusional state—Epirubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Budesonide—Infection—Epirubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Budesonide—Cough—Doxorubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Budesonide—Shock—Epirubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—testicular cancer	0.000653	0.000653	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000648	0.000648	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Budesonide—Insomnia—Methotrexate—testicular cancer	0.000643	0.000643	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000638	0.000638	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Budesonide—Anorexia—Epirubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—testicular cancer	0.000634	0.000634	CcSEcCtD
Budesonide—Somnolence—Methotrexate—testicular cancer	0.000632	0.000632	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—testicular cancer	0.000626	0.000626	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—testicular cancer	0.000618	0.000618	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000614	0.000614	CcSEcCtD
Budesonide—Fatigue—Methotrexate—testicular cancer	0.000613	0.000613	CcSEcCtD
Budesonide—Infection—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Budesonide—Pain—Methotrexate—testicular cancer	0.000608	0.000608	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000607	0.000607	CcSEcCtD
Budesonide—Shock—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Budesonide—Insomnia—Epirubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Budesonide—Somnolence—Epirubicin—testicular cancer	0.000592	0.000592	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000582	0.000582	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000575	0.000575	CcSEcCtD
Budesonide—Fatigue—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Budesonide—Pain—Epirubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Budesonide—Constipation—Epirubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Budesonide—Urticaria—Methotrexate—testicular cancer	0.000565	0.000565	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Budesonide—Urticaria—Epirubicin—testicular cancer	0.000529	0.000529	CcSEcCtD
Budesonide—Constipation—Doxorubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Budesonide—Pain—Doxorubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—testicular cancer	0.000524	0.000524	CcSEcCtD
Budesonide—Asthenia—Methotrexate—testicular cancer	0.00051	0.00051	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Budesonide—Pruritus—Methotrexate—testicular cancer	0.000503	0.000503	CcSEcCtD
Budesonide—Hypersensitivity—Epirubicin—testicular cancer	0.00049	0.00049	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—testicular cancer	0.000487	0.000487	CcSEcCtD
Budesonide—Asthenia—Epirubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Budesonide—Pruritus—Epirubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Budesonide—Dizziness—Methotrexate—testicular cancer	0.00047	0.00047	CcSEcCtD
Budesonide—Diarrhoea—Epirubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Budesonide—Vomiting—Methotrexate—testicular cancer	0.000452	0.000452	CcSEcCtD
Budesonide—Rash—Methotrexate—testicular cancer	0.000449	0.000449	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—testicular cancer	0.000448	0.000448	CcSEcCtD
Budesonide—Headache—Methotrexate—testicular cancer	0.000446	0.000446	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—testicular cancer	0.000442	0.000442	CcSEcCtD
Budesonide—Dizziness—Epirubicin—testicular cancer	0.00044	0.00044	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Budesonide—Vomiting—Epirubicin—testicular cancer	0.000423	0.000423	CcSEcCtD
Budesonide—Nausea—Methotrexate—testicular cancer	0.000423	0.000423	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—testicular cancer	0.000421	0.000421	CcSEcCtD
Budesonide—Rash—Epirubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Budesonide—Headache—Epirubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—testicular cancer	0.000407	0.000407	CcSEcCtD
Budesonide—Nausea—Epirubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—testicular cancer	0.000392	0.000392	CcSEcCtD
Budesonide—Rash—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Budesonide—Headache—Doxorubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Budesonide—Nausea—Doxorubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
